Results 41 to 50 of about 2,498 (139)

A case of rapidly increasing cabergoline-resistant male prolactinoma

Interdisciplinary Neurosurgery
Cabergoline, a dopamine agonist, is the first-line drug for treating prolactinoma. However, some rare cases exhibit resistance to cabergoline. Here, we report a rare case of prolactinoma in a male patient that recurred in a short period while the patient
Toshiya Ichinose, Yasuo Sasagawa, Mitsutoshi Nakada   +2 more
doaj   +1 more source

Clomiphene citrate plus cabergoline versus clomiphene citrate for induction of ovulation in infertile euprolactinemic patients with polycystic ovary syndrome: A randomized clinical trial

Middle East Fertility Society Journal, 2018
Objective: To compare the effect of adjunctive use of cabergoline with clomiphene citrate (CC) in infertile polycystic ovarian syndrome (PCOS) patients with normal prolactin level. Study design: A randomized clinical trial (NCT 02644304). Setting: Assiut
Kamal M. Zahran, Waleed A. Mostafa, Ahmed M. Abbas, Mansour A. Khalifa, Gamal H. Sayed   +4 more
doaj   +1 more source

Combination of dopamine agonist and prostaglandin administration for pregnancy termination in bitches – a novel approach

Journal of Applied Animal Research, 2020
Pregnancy termination is a required procedure in companion animal practice. In healthy bitches with confirmed pregnancy, good results are obtained with the combination of prostaglandin F2 and dopamine agonist, followed by regular sonographic examination ...
Branimira Špoljarić, Davor Svoboda, Darko Gereš, Silvijo Vince, Daniel Špoljarić, Maja Popović, Damir Žubčić, I. Butković, J. Šavorić, J. Grizelj, M. Samardžija   +10 more
doaj   +1 more source

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma

Endocrine Oncology, 2023
Cabergoline-associated valvulopathy (CAV) is defined by the echocardiographic triad of moderate or severe regurgitation, valvular thickening and restricted valvular motion.
Annabelle G Hayes, Masoumeh G Shirazi, Anand Thiyagarajah, David J Torpy, Sunita M C De Sousa   +4 more
doaj   +1 more source

Predictors of in vitro response to somatostatin and dopamine receptor‐targeted treatments are lacking in clinically non‐functioning pituitary tumors

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Clinically non‐functioning pituitary neuroendocrine tumors (NF‐PitNETs) lack effective medical therapies, and the role of somatostatin receptor ligands (SRLs) and dopamine agonists (DAs) in this setting is controversial. We evaluated the in vitro response of NF‐PitNETs to multiple SRL and/or DA treatments, focusing on the role of receptor ...
Claudia Campana, Jessica Amarù, Diego Criminelli Rossi, Anna Arecco, Paolo Nozza, Mara Boschetti, Gianluigi Zona, Diego Ferone, Marica Arvigo, Federico Gatto   +9 more
wiley   +1 more source

Prolactinomas in the transition from adolescence to young adulthood: A multicentre, retrospective study from the TALENT group

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Prolactinomas in the transition age present unique challenges; treatment strategies and long‐term outcomes in this population remain incompletely characterised. This is a multicentre, retrospective study of 110 consecutive patients (33 males) with prolactinomas, aged 15–25 years, across five Italian referral centres (2010–2025).
Dario De Alcubierre, Claudia Giavoli, Tiziana Feola, Lorenzo Cerroni, Ludovica Vincenzi, Eriselda Profka, Aurora Pedroli, Giulia Puliani, Rosa Pirchio, Marta Tenuta, Renata S. Auriemma, Maria Luisa Appetecchia, Rosario Pivonello, Giovanna Mantovani, Andrea M. Isidori, Marie‐Lise Jaffrain‐Rea, Ashley Grossman, Emilia Sbardella   +17 more
wiley   +1 more source

Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection [PDF]

International Journal of Fertility and Sterility, 2018
Background The aim of the current study is to compare quinagolide with cabergoline in prevention of ovarian hyperstimulation syndrome (OHSS) among high risk women undergoing intracytoplasmic sperm injection (ICSI).
Robabeh Taheripanah, Mahshid Vasef, Marzieh Zamaniyan, Anahita Taheripanah   +3 more
doaj   +1 more source

Severe Hypernatraemia Secondary to Adipsia Associated With a Pituitary Macroadenoma in a Dog: A Case Report

Veterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Severe hypernatraemia (Na+ 192 mmol/L) secondary to adipsia was successfully managed through gradual sodium correction, close monitoring and assisted water supplementation in a dog with a pituitary macroadenoma. No neurologic complications occurred during correction, and serum sodium concentrations remained stable for 9 months. This case highlights the
Gyo‐Bin Choo, Bum‐kyu Choi, Sooyoung Choi, Daji Noh, Ju‐Hyun An   +4 more
wiley   +1 more source

Cabergoline for Cushing's disease: a large retrospective multicenter study.

, 2017
peer reviewedOBJECTIVE: The efficacy of cabergoline in Cushing's disease (CD) is controversial. The aim of this study was to assess the efficacy and tolerability of cabergoline in a large contemporary cohort of patients with CD.
Chabre, Olivier, Cortet, Chrisitine, Delemer, B., Maiter, D., Briet, C., Beckers, Albert, Cephise-Velayoudom, F. L., Tabarin, Antoine, Maiter, Dominique, Castinetti, Frédéric, Chanson, Philippe, Castinetti, F., Haissaguerre, M., Briet, Claire, Caron, Philippe, Ferriere, Amandine, Delemer, Brigitte, Nunes, M. L., Raingeard, I., Bertherat, Jérôme, Cephise-Velayoudom, Fritz Line, Haissaguerre, Magalie, Caron, P., Reznik, Yves, Rohmer, Vincent, Chabre, O., Nunes, Marie Laure, Chanson, P., Cortet, C., Rohmer, V., Tabarin, A., VROONEN, Laurent, Ferriere, A., Reznik, Y., Raingeard, Isabelle, Bertherat, J.   +35 more
core   +1 more source

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

Current Therapeutic Research, 2021
: Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like ...
Mohammed Fouad Shalaby, MD, Hekma A. Abd El Latif, PhD, Mohamed El Yamani, PhD, May Ahmed Galal, PhD, Sherifa Kamal, PhD, Ikhlas Sindi, PhD   +5 more
doaj   +1 more source